TP53 and glioblastoma: Although few core pathways, namely EGFR, RTK/PI3K, p53 and RB regulation, are suspected as initial drivers of proliferation and tumor initiation (50, 51), established glioblastoma diversify into multiple subclonal populations, rendering glioblastoma a highly heterogenic cancer (52).